General Information of Drug (ID: DM3W15N)

Drug Name
Calcium carbimide
Synonyms
Nitrolime; Alzodef; Aero cyanamid granular; USAF CY-2; Aero cyanamid special grade; Nitrolim; Cyanamid; Calcium cyanamid; Lime Nitroget; Cyanamid granular; NCI-C02937; CY-L 500; Cyanamid special grade; UN 1403, Nitrolime; WLN: CA NCN; NSC7078; NSC-7078
Indication
Disease Entry ICD 11 Status REF
Alcohol dependence 6C40.2 Approved [1]
Drug Type
Small molecular drug
Structure
3D MOL is unavailable 2D MOL
#Ro5 Violations (Lipinski):
0
Molecular Weight 80.1
Topological Polar Surface Area Not Available
Rotatable Bond Count 0
Hydrogen Bond Donor Count 0
Hydrogen Bond Acceptor Count 2
ADMET Property
Absorption Cmax
The maximum plasma concentration (Cmax) of drug is 158 mcg/L [2]
Absorption Tmax
The time to maximum plasma concentration (Tmax) is 6 h [2]
Bioavailability
The bioavailability of drug is 45% [2]
Clearance
The total plasma clearance of drug is 0.0123-0.0190 L/min/kg [3]
Elimination
The rate of elimination of ethanol when calcium carbimide is administered tends to be around 5% slower than the one presented in patients without any treatment [4]
Half-life
The concentration or amount of drug in body reduced by one-half in 92.4 minutes [5]
Vd
The volume of distribution (Vd) of drug is 0.64 L/kg [6]
Chemical Identifiers
Formula
CCaN2
IUPAC Name
calcium;azanidylidenemethylideneazanide
Canonical SMILES
C(=[N-])=[N-].[Ca+2]
InChI
InChI=1S/CN2.Ca/c2-1-3;/q-2;+2
InChIKey
MYFXBBAEXORJNB-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
56955933
ChEBI ID
CHEBI:64301
CAS Number
156-62-7
DrugBank ID
DB09116
TTD ID
D0A9KF
INTEDE ID
DR0261

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Acetaldehyde dehydrogenase (ALDH) TTCTAOJ AL1A1_HUMAN; ALDH2_HUMAN; AL1B1_HUMAN Inhibitor [7]

Drug-Metabolizing Enzyme (DME)
DME Name DME ID UniProt ID MOA REF
Catalase (CAT)
Main DME
DE1XPGH CATA_HUMAN Substrate [8]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2 Patnaik A, Rosen LS, Tolaney SM, Tolcher AW, Goldman JW, Gandhi L, Papadopoulos KP, Beeram M, Rasco DW, Hilton JF, Nasir A, Beckmann RP, Schade AE, Fulford AD, Nguyen TS, Martinez R, Kulanthaivel P, Li LQ, Frenzel M, Cronier DM, Chan EM, Flaherty KT, Wen PY, Shapiro GI: Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Other Solid Tumors. Cancer Discov. 2016 Jul;6(7):740-53. doi: 10.1158/2159-8290.CD-16-0095. Epub 2016 May 23.
3 Colom H, Prunonosa J, Peraire C, Domenech J, Azcona O, Torrent J, Obach R: Absolute bioavailability and absorption profile of cyanamide in man. J Pharmacokinet Biopharm. 1999 Aug;27(4):421-36.
4 Jones AW, Neiman J, Hillbom M: Elimination kinetics of ethanol and acetaldehyde in healthy men during the calcium carbimide-alcohol flush reaction. Alcohol Alcohol Suppl. 1987;1:213-7.
5 Encyclopedia
6 Jones AW, Neiman J, Hillbom M: Concentration-time profiles of ethanol and acetaldehyde in human volunteers treated with the alcohol-sensitizing drug, calcium carbimide. Br J Clin Pharmacol. 1988 Feb;25(2):213-21.
7 Disulfiram and calcium carbimide. Mode of action, adverse effects and clinical use. Tidsskr Nor Laegeforen. 1990 Apr 10;110(10):1224-8.
8 Vasiliou V. and Petersen D. (2010). Comprehensive toxicology (2nd ed.). Elsevier.
9 Catalase and glutathione peroxidase are equally active in detoxification of hydrogen peroxide in human erythrocytes. Blood. 1989 Jan;73(1):334-9.